0001104659-20-106765.txt : 20200921 0001104659-20-106765.hdr.sgml : 20200921 20200921081115 ACCESSION NUMBER: 0001104659-20-106765 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200917 FILED AS OF DATE: 20200921 DATE AS OF CHANGE: 20200921 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Clauser Noah CENTRAL INDEX KEY: 0001796466 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37467 FILM NUMBER: 201185232 MAIL ADDRESS: STREET 1: 100 HIGH STREET STREET 2: 28TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CATABASIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001454789 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE KENDALL SQUARE STREET 2: BLDG. 1400E, SUITE B14202 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-349-1971 MAIL ADDRESS: STREET 1: ONE KENDALL SQUARE STREET 2: BLDG. 1400E, SUITE B14202 CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 a4.xml 4 X0306 4 2020-09-17 0 0001454789 CATABASIS PHARMACEUTICALS INC CATB 0001796466 Clauser Noah C/O CATABASIS PHARMACEUTICALS, INC., 100 HIGH STREET, FLOOR 28 BOSTON MA 02110 0 1 0 0 Chief Financial Officer Stock Option (right to buy) 6.94 2020-09-17 4 A 0 35000 0 A 2030-09-16 Common Stock 35000 35000 D This option was granted on September 17, 2020 and is subject to vesting over a four year period with 25% of the shares vesting on the first anniversary of September 17, 2020 and the remainder vesting over the ensuing three years at a rate of 2.0833% per month. /s/ Noah Clauser 2020-09-21